首页 > 最新文献

Research in Cardiovascular Medicine最新文献

英文 中文
Sawtooth cardiomyopathy 锯齿心肌病
IF 0.3 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2022-07-01 DOI: 10.4103/rcm.rcm_14_22
Zahra Ansari, S. Saedi, N. Rezaeian
Sawtooth cardiomyopathy (STC) is a kind of left ventricular (LV) dysplasia which was falsely classified as a variant of LV noncompaction. Here, we report a young man case with presyncope and dyspnea during exercise. Echocardiographic and cardiac magnetic resonance features showed multiple ridge-like projections of compacted myocardium in the inferior and lateral wall which was compatible with diagnosis of STC.
锯齿状心肌病(STC)是左室(LV)发育不良的一种,被错误地归类为左室不压实的一种变体。在此,我们报告一个年轻男性在运动时出现晕厥前和呼吸困难的病例。超声心动图及心脏磁共振示下侧壁多发脊状致密心肌突出,符合STC诊断。
{"title":"Sawtooth cardiomyopathy","authors":"Zahra Ansari, S. Saedi, N. Rezaeian","doi":"10.4103/rcm.rcm_14_22","DOIUrl":"https://doi.org/10.4103/rcm.rcm_14_22","url":null,"abstract":"Sawtooth cardiomyopathy (STC) is a kind of left ventricular (LV) dysplasia which was falsely classified as a variant of LV noncompaction. Here, we report a young man case with presyncope and dyspnea during exercise. Echocardiographic and cardiac magnetic resonance features showed multiple ridge-like projections of compacted myocardium in the inferior and lateral wall which was compatible with diagnosis of STC.","PeriodicalId":21031,"journal":{"name":"Research in Cardiovascular Medicine","volume":"11 1","pages":"89 - 90"},"PeriodicalIF":0.3,"publicationDate":"2022-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44385585","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Predicting cardiac index using the electrocardiogram in pulmonary hypertension patients 肺动脉高压患者心电图预测心脏指数
IF 0.3 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2022-07-01 DOI: 10.4103/rcm.rcm_11_22
M. Mirtajaddini, N. Naderi, Khadije Mohammadi, S. Taghavi, Maryam Maharloo, S. Mazloomzadeh, A. Amin
Background: Pulmonary hypertension (PH) is a fatal disease where on-time treatment can change the prognosis. The selection of treatment is dictated by the severity of PH. The cardiac index (CI) is a robust indicator of PH severity. This trial aimed to find out the association between electrocardiogram (ECG) data and CI as a prognostic factor of PH. Methods: Ninety-five patients with precapillary PH were included in the study. The cardiac output of patients was calculated using the right heart catheterization and the Fick formula. Patients were categorized into low- and high-risk groups based on the CI. Their ECGs were interpreted by an expert cardiologist. The association between ECG parameters and severity of PH was evaluated based on the CI. Results: The median age of patients was 36 years. The mean of CI was 2.35 L/min/m2 with a standard deviation of 0.74. About 36% of patients were in the high-risk category based on the CI. Among ECG parameters, ST segment depression in V1-V6 and R/S ratio ≥1 in V1 were found significantly correlated with CI for high-risk category (P = 0.026). Conclusion: ST segment depression in V1-V6 and R/S ratio ≥1 in V1 had a significant association with CI in the range lower than 2 L/min/m2, which is an indicator of poor PH prognosis. Therefore, these variables can be used as an inexpensive and available prognostic factor in patients with precapillary PH.
背景:肺动脉高压(PH)是一种致命的疾病,及时治疗可以改变预后。治疗的选择取决于PH的严重程度。心脏指数(CI)是PH严重程度的有力指标。本试验旨在找出心电图(ECG)数据与CI之间的关系,CI是PH的预后因素。方法:95例毛细血管前PH患者纳入本研究。使用右心导管插入术和Fick公式计算患者的心输出量。根据CI将患者分为低风险组和高风险组。他们的心电图由心脏病专家解释。根据CI评估心电图参数与PH严重程度之间的相关性。结果:患者的中位年龄为36岁。CI的平均值为2.35L/min/m2,标准偏差为0.74。根据CI,约36%的患者属于高危类别。在心电图参数中,V1-V6的ST段压低和V1的R/S比≥1与高危类别的CI显著相关(P=0.026),这是PH预后不良的指标。因此,这些变量可以作为毛细血管前PH患者的一个廉价且可用的预后因素。
{"title":"Predicting cardiac index using the electrocardiogram in pulmonary hypertension patients","authors":"M. Mirtajaddini, N. Naderi, Khadije Mohammadi, S. Taghavi, Maryam Maharloo, S. Mazloomzadeh, A. Amin","doi":"10.4103/rcm.rcm_11_22","DOIUrl":"https://doi.org/10.4103/rcm.rcm_11_22","url":null,"abstract":"Background: Pulmonary hypertension (PH) is a fatal disease where on-time treatment can change the prognosis. The selection of treatment is dictated by the severity of PH. The cardiac index (CI) is a robust indicator of PH severity. This trial aimed to find out the association between electrocardiogram (ECG) data and CI as a prognostic factor of PH. Methods: Ninety-five patients with precapillary PH were included in the study. The cardiac output of patients was calculated using the right heart catheterization and the Fick formula. Patients were categorized into low- and high-risk groups based on the CI. Their ECGs were interpreted by an expert cardiologist. The association between ECG parameters and severity of PH was evaluated based on the CI. Results: The median age of patients was 36 years. The mean of CI was 2.35 L/min/m2 with a standard deviation of 0.74. About 36% of patients were in the high-risk category based on the CI. Among ECG parameters, ST segment depression in V1-V6 and R/S ratio ≥1 in V1 were found significantly correlated with CI for high-risk category (P = 0.026). Conclusion: ST segment depression in V1-V6 and R/S ratio ≥1 in V1 had a significant association with CI in the range lower than 2 L/min/m2, which is an indicator of poor PH prognosis. Therefore, these variables can be used as an inexpensive and available prognostic factor in patients with precapillary PH.","PeriodicalId":21031,"journal":{"name":"Research in Cardiovascular Medicine","volume":"11 1","pages":"76 - 80"},"PeriodicalIF":0.3,"publicationDate":"2022-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44654057","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A clinical trial of comparing dexmedetomidine and remifentanil on the oximetry parameters in the patients with end-stage renal disease undergoing arteriovenous fistula formation 右美托咪定与瑞芬太尼对终末期肾病动静脉瘘患者血氧测定参数的比较
IF 0.3 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2022-07-01 DOI: 10.4103/rcm.rcm_12_22
R. Dolatabadi, S. Motlagh, Mohamadreza Ghodraty, A. Shafeinia, A. Maleki, Z. Norouzi, Shiva Khaleghparast
Background: Oximetry is a method for measuring the arterial hemoglobin saturation (SpO2) using pulse oximeter and is essential in any type of anesthetic procedures. The growing population of geriatrics in the recent decades in combination with an increase in the prevalence of chronic diseases including diabetes and hypertension are some of the leading causes for an increase in the prevalence of chronic kidney disease and end-stage renal disease (ESRD). The definite treatment for ESRD is renal transplant but unfortunately, it may take a long time to find a suitable kidney and continuing the patient's life may depend on dialysis. Arteriovenous fistula (AVF) formation is one of the first steps to prepare the patient for hemodialysis. ESRD itself is a reason for physical and psychosocial issues. Preparing a favorable condition for AVF surgery is essential to decrease the burden of the underlying disease. An efficient respiratory supply is necessary in all parts of an anesthetic procedures. Aims and Objectives: This study is a double-blind clinical trial to compare two anesthetic agents, dexmedetomidine and remifentanil in patients with ESRD who underwent AVF formation. Materials and Methods: SpO2 was measured on different phases including the time of initial incision, and after 10, 30, 60, 90, and 120 min of finishing the surgery. The data were analyzed using SPSS version 22, two-way repeated measures (ANOVA), and independent t-test. Results: This study showed that there was no any significant difference in using any of these two agents with regard to SpO2 in the different times of measurements during the anesthetic procedure and after the surgery in the recovery phase. Conclusion: This study showed that there is not any superiority in using DEX or REM in the patients undergo AVF formation. More studies on the other groups of the patients with different surgeries.
背景:血氧仪是一种使用脉搏血氧仪测量动脉血红蛋白饱和度(SpO2)的方法,在任何类型的麻醉过程中都是必不可少的。近几十年来,老年人口的不断增长,加上慢性疾病(包括糖尿病和高血压)患病率的增加,是慢性肾病和终末期肾病(ESRD)患病率增加的一些主要原因。ESRD的明确治疗是肾脏移植,但不幸的是,可能需要很长时间才能找到合适的肾脏,并且患者的生命可能依赖于透析。动静脉瘘(AVF)的形成是准备患者进行血液透析的第一步。ESRD本身就是身体和社会心理问题的一个原因。为AVF手术准备一个有利的条件对于减少潜在疾病的负担至关重要。有效的呼吸供应在麻醉过程的所有环节都是必要的。目的和目的:本研究是一项双盲临床试验,比较右美托咪定和瑞芬太尼两种麻醉剂在发生AVF形成的ESRD患者中的作用。材料与方法:在初始切口时间及手术结束后10、30、60、90、120 min测定SpO2。数据分析采用SPSS version 22、双向重复测量(ANOVA)和独立t检验。结果:本研究显示,在麻醉过程中和手术后恢复期的不同测量时间,使用这两种药物的SpO2均无显著差异。结论:本研究表明,在AVF形成患者中使用DEX或REM没有任何优势。对其他组不同手术的患者进行了更多的研究。
{"title":"A clinical trial of comparing dexmedetomidine and remifentanil on the oximetry parameters in the patients with end-stage renal disease undergoing arteriovenous fistula formation","authors":"R. Dolatabadi, S. Motlagh, Mohamadreza Ghodraty, A. Shafeinia, A. Maleki, Z. Norouzi, Shiva Khaleghparast","doi":"10.4103/rcm.rcm_12_22","DOIUrl":"https://doi.org/10.4103/rcm.rcm_12_22","url":null,"abstract":"Background: Oximetry is a method for measuring the arterial hemoglobin saturation (SpO2) using pulse oximeter and is essential in any type of anesthetic procedures. The growing population of geriatrics in the recent decades in combination with an increase in the prevalence of chronic diseases including diabetes and hypertension are some of the leading causes for an increase in the prevalence of chronic kidney disease and end-stage renal disease (ESRD). The definite treatment for ESRD is renal transplant but unfortunately, it may take a long time to find a suitable kidney and continuing the patient's life may depend on dialysis. Arteriovenous fistula (AVF) formation is one of the first steps to prepare the patient for hemodialysis. ESRD itself is a reason for physical and psychosocial issues. Preparing a favorable condition for AVF surgery is essential to decrease the burden of the underlying disease. An efficient respiratory supply is necessary in all parts of an anesthetic procedures. Aims and Objectives: This study is a double-blind clinical trial to compare two anesthetic agents, dexmedetomidine and remifentanil in patients with ESRD who underwent AVF formation. Materials and Methods: SpO2 was measured on different phases including the time of initial incision, and after 10, 30, 60, 90, and 120 min of finishing the surgery. The data were analyzed using SPSS version 22, two-way repeated measures (ANOVA), and independent t-test. Results: This study showed that there was no any significant difference in using any of these two agents with regard to SpO2 in the different times of measurements during the anesthetic procedure and after the surgery in the recovery phase. Conclusion: This study showed that there is not any superiority in using DEX or REM in the patients undergo AVF formation. More studies on the other groups of the patients with different surgeries.","PeriodicalId":21031,"journal":{"name":"Research in Cardiovascular Medicine","volume":"11 1","pages":"66 - 70"},"PeriodicalIF":0.3,"publicationDate":"2022-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47248218","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparative study to assess the effect of priming solutions (Plasmalyte-A and Ringer Lactate) on Acid–base balance during cardiopulmonary bypass for adult cardiac surgery 血浆- a和乳酸林格液对成人心脏手术体外循环患者酸碱平衡影响的比较研究
IF 0.3 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2022-04-01 DOI: 10.4103/rcm.rcm_65_21
Amit Vashisth, Yasir Saleem, Anshuman Darbari, Anish Gupta, R. Lahiri, Ajay Kumar
Background: Priming solution used in cardiopulmonary bypass has different impact on body, primarily on the metabolic acidosis and electrolytes. This observational comparative study was done to find the metabolic effects of Ringer lactate and Plasmalyte-A as priming solutions for various metabolic parameters during adult cardiac surgery. Materials and Methods: In the present study, 52 subjects were included who received different priming solutions. Subjects were categorized into two groups. Group P received Plasmalyte-A as prime and Group R received Ringer lactate. From all these cases, samples were collected at predefined time durations, and results were compared between both groups. Observation and Results: A total of 52 patients were evaluated for the metabolic changes concerning different priming solutions. Group P included the subject who received Plasmalyte-A as pump prime (n = 26), and Ringer lactate was used as pump prime in Group R (n = 26). We compared various parameters such as pH: In Group R, a decrease in pH was statistically significant with P < 0.05 at 40 min of bypass (T40) and P < 0.05 at 6 h of postbypass (T6). Base Excess: The mean value in Group P was − 1.72 ± 2.18 and − 3.16 ± 2.48 and in Group R at 30 min of bypass (T30). A statistically significance was found between the two groups for this parameter (P < 0.05). Lactate and Strong Ions Difference: A statistically significant data were found between the two groups for this parameter throughout the bypass as well as postoperative hours with the P < 0.05. Conclusion: Plasmalyte-A is more favorable crystalloid solution as a pump prime fluid as it helped to maintain satisfactory metabolic parameters with less metabolic acidosis during adult cardiac surgeries.
背景:体外循环中使用的启动液对身体有不同的影响,主要是对代谢性酸中毒和电解质的影响。这项观察性比较研究旨在发现乳酸林格和Plasmalyte-A作为成人心脏手术期间各种代谢参数的启动溶液的代谢效应。材料和方法:在本研究中,52名受试者接受了不同的引发溶液。受试者被分为两组。P组接受Plasmalyte-A作为主要原料,R组接受乳酸林格。从所有这些病例中,在预定的时间内收集样本,并比较两组之间的结果。观察和结果:共有52名患者评估了不同引发溶液的代谢变化。P组包括接受Plasmalyte-A作为泵送素的受试者(n=26),并且在R组中使用乳酸林格作为泵送剂(n=26)。我们比较了各种参数,如pH值:在R组中,pH值的降低具有统计学意义,在旁路40分钟(T40)时P<0.05,在旁路6小时(T6)时P<0.05。基础过量:P组的平均值为−1.72±2.18和−3.16±2.48,R组在搭桥30分钟(T30)时的平均值。这一参数在两组之间具有统计学意义(P<0.05)。乳酸和强离子差异:在整个搭桥术和术后数小时内,两组之间的这一参数数据具有统计学意义,P<0.05。结论:Plasmalyte-A是一种更有利的晶体溶液,作为泵送的主要液体,因为它有助于在成人心脏手术中保持令人满意的代谢参数,减少代谢性酸中毒。
{"title":"Comparative study to assess the effect of priming solutions (Plasmalyte-A and Ringer Lactate) on Acid–base balance during cardiopulmonary bypass for adult cardiac surgery","authors":"Amit Vashisth, Yasir Saleem, Anshuman Darbari, Anish Gupta, R. Lahiri, Ajay Kumar","doi":"10.4103/rcm.rcm_65_21","DOIUrl":"https://doi.org/10.4103/rcm.rcm_65_21","url":null,"abstract":"Background: Priming solution used in cardiopulmonary bypass has different impact on body, primarily on the metabolic acidosis and electrolytes. This observational comparative study was done to find the metabolic effects of Ringer lactate and Plasmalyte-A as priming solutions for various metabolic parameters during adult cardiac surgery. Materials and Methods: In the present study, 52 subjects were included who received different priming solutions. Subjects were categorized into two groups. Group P received Plasmalyte-A as prime and Group R received Ringer lactate. From all these cases, samples were collected at predefined time durations, and results were compared between both groups. Observation and Results: A total of 52 patients were evaluated for the metabolic changes concerning different priming solutions. Group P included the subject who received Plasmalyte-A as pump prime (n = 26), and Ringer lactate was used as pump prime in Group R (n = 26). We compared various parameters such as pH: In Group R, a decrease in pH was statistically significant with P < 0.05 at 40 min of bypass (T40) and P < 0.05 at 6 h of postbypass (T6). Base Excess: The mean value in Group P was − 1.72 ± 2.18 and − 3.16 ± 2.48 and in Group R at 30 min of bypass (T30). A statistically significance was found between the two groups for this parameter (P < 0.05). Lactate and Strong Ions Difference: A statistically significant data were found between the two groups for this parameter throughout the bypass as well as postoperative hours with the P < 0.05. Conclusion: Plasmalyte-A is more favorable crystalloid solution as a pump prime fluid as it helped to maintain satisfactory metabolic parameters with less metabolic acidosis during adult cardiac surgeries.","PeriodicalId":21031,"journal":{"name":"Research in Cardiovascular Medicine","volume":"11 1","pages":"49 - 53"},"PeriodicalIF":0.3,"publicationDate":"2022-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45491597","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Does the timing of treatment with intraaortic balloon pump in cardiac surgery affect survival? 心脏手术中主动脉内球囊泵治疗的时机是否会影响生存率?
IF 0.3 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2022-04-01 DOI: 10.4103/rcm.rcm_71_21
Amin Bagheri, Behrooz Banivaheb, Matineh Heidari, J. Bagheri
Background: The intraaortic balloon pump (IABP) is the most common mechanical assist device used as an adjunctive therapy for patients with low cardiac output among cardiac surgery. However, controversy still exists about the optimal time for IABP insertion. The study evaluated the association between timing of IABP insertion and outcome in cardiac surgical patients. Patients and Methods: Patients who underwent cardiac surgery between August 2007 and June 2014 were included. 273 of 3480 patients (7.84%) required perioperative IABP support. Of whom 21 (7.7%) received a preoperative IABP, 180 (65.9%) received an intraoperative IABP and 72 (26.4%) received a postoperative IABP. Predictors of early mortality were measured in stepwise multivariate logistic regression analyses. Results: The overall mortality rate for all patients requiring IABP was 29.3%. The incidence of mortality in patients who underwent pre-, intra- and postoperative IABP insertion was 19.0%, 22.8%, and 48.6%, respectively. The independent predictors of early mortality were age, cross clamp time, and postoperative IABP. However, either pre or intraoperative IABP insertion was not associated with increase in early mortality. Conclusions: IABP treatment in patients undergoing cardiac surgery was relatively safe accompanied by few complications. Timing of IABP insertion appears to be associated with survival as early insertion results are much more desirable compared to postoperative insertion.
背景:主动脉内球囊泵(IABP)是心脏手术中最常见的辅助治疗低心输出量患者的机械辅助装置。然而,关于IABP插入的最佳时间仍然存在争议。该研究评估了心脏外科患者IABP插入时机与结果之间的关系。患者和方法:纳入2007年8月至2014年6月期间接受心脏手术的患者。3480名患者中有273名(7.84%)需要围手术期IABP支持。其中21例(7.7%)接受术前IABP,180例(65.9%)接受术中IABP,72例(26.4%)接受术后IABP。早期死亡率的预测因素采用逐步多元逻辑回归分析。结果:所有需要IABP的患者的总死亡率为29.3%。接受IABP插入术前、术中和术后患者的死亡率分别为19.0%、22.8%和48.6%。早期死亡率的独立预测因素是年龄、交叉钳夹时间和术后IABP。然而,术前或术中植入IABP与早期死亡率的增加无关。结论:IABP治疗心脏手术患者相对安全,并发症少。IABP插入时机似乎与生存率相关,因为与术后插入相比,早期插入结果更可取。
{"title":"Does the timing of treatment with intraaortic balloon pump in cardiac surgery affect survival?","authors":"Amin Bagheri, Behrooz Banivaheb, Matineh Heidari, J. Bagheri","doi":"10.4103/rcm.rcm_71_21","DOIUrl":"https://doi.org/10.4103/rcm.rcm_71_21","url":null,"abstract":"Background: The intraaortic balloon pump (IABP) is the most common mechanical assist device used as an adjunctive therapy for patients with low cardiac output among cardiac surgery. However, controversy still exists about the optimal time for IABP insertion. The study evaluated the association between timing of IABP insertion and outcome in cardiac surgical patients. Patients and Methods: Patients who underwent cardiac surgery between August 2007 and June 2014 were included. 273 of 3480 patients (7.84%) required perioperative IABP support. Of whom 21 (7.7%) received a preoperative IABP, 180 (65.9%) received an intraoperative IABP and 72 (26.4%) received a postoperative IABP. Predictors of early mortality were measured in stepwise multivariate logistic regression analyses. Results: The overall mortality rate for all patients requiring IABP was 29.3%. The incidence of mortality in patients who underwent pre-, intra- and postoperative IABP insertion was 19.0%, 22.8%, and 48.6%, respectively. The independent predictors of early mortality were age, cross clamp time, and postoperative IABP. However, either pre or intraoperative IABP insertion was not associated with increase in early mortality. Conclusions: IABP treatment in patients undergoing cardiac surgery was relatively safe accompanied by few complications. Timing of IABP insertion appears to be associated with survival as early insertion results are much more desirable compared to postoperative insertion.","PeriodicalId":21031,"journal":{"name":"Research in Cardiovascular Medicine","volume":"11 1","pages":"43 - 48"},"PeriodicalIF":0.3,"publicationDate":"2022-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48197435","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Geophagy is a worldwide health hazard for pregnant women: A view 食土癖是全世界孕妇的健康危害:观点
IF 0.3 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2022-04-01 DOI: 10.4103/rcm.rcm_8_22
Muhammad Islam, Anup De
{"title":"Geophagy is a worldwide health hazard for pregnant women: A view","authors":"Muhammad Islam, Anup De","doi":"10.4103/rcm.rcm_8_22","DOIUrl":"https://doi.org/10.4103/rcm.rcm_8_22","url":null,"abstract":"","PeriodicalId":21031,"journal":{"name":"Research in Cardiovascular Medicine","volume":"11 1","pages":"57 - 58"},"PeriodicalIF":0.3,"publicationDate":"2022-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44749094","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lateral wall ischemia secondary to funnel-shaped left main coronary artery aneurysm with stenotic osteoproximal left circumflex coronary artery in a child with recent recovery from kawasaki disease: A case report and review of literature 川崎病近期康复儿童漏斗形左主冠状动脉瘤伴左回旋支狭窄继发侧壁缺血1例报告及文献复习
IF 0.3 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2022-04-01 DOI: 10.4103/rcm.rcm_70_21
Debasish Das, A. Banerjee, Tutan Das, Manaranjan Dixit, Abhinav Kumar, S. Singh
We present a case of funnel-shaped aneurysmal dilatation of left main coronary artery (LMCA) with aggressive stenosis of osteoproximal left circumflex coronary artery presenting with lateral wall coronary ischemia in a 6-year-old school-going child who recovered from Kawasaki disease (KD) 1 month back. Although aneurysmal dilatation of LMCA during first 2 months of recovery from KD is well known, with median duration for the development of stenotic lesion in coronaries after KD is approximately 6 months and all the cases of coronary stenosis described so far have been described in the presence of large coronary artery aneurysm, our case is rare to illustrate aggressive stenosis of osteoproximal left circumflex coronary artery just after 1 month of recovery in spite of the presence of small coronary artery aneurysm.
我们报告了一例左主冠状动脉(LMCA)漏斗状动脉瘤样扩张伴骨近端左回旋支严重狭窄,表现为侧壁冠状动脉缺血的病例,该病例发生在一个月前从川崎病(KD)康复的6岁学龄儿童身上。尽管在KD恢复的前2个月,LMCA的动脉瘤扩张是众所周知的,但KD后冠状动脉狭窄病变发展的中位持续时间约为6个月,并且迄今为止描述的所有冠状动脉狭窄病例都是在存在大冠状动脉瘤的情况下描述的,尽管存在小的冠状动脉瘤,但我们的病例很少显示在恢复1个月后,旋左冠状动脉骨端发生严重狭窄。
{"title":"Lateral wall ischemia secondary to funnel-shaped left main coronary artery aneurysm with stenotic osteoproximal left circumflex coronary artery in a child with recent recovery from kawasaki disease: A case report and review of literature","authors":"Debasish Das, A. Banerjee, Tutan Das, Manaranjan Dixit, Abhinav Kumar, S. Singh","doi":"10.4103/rcm.rcm_70_21","DOIUrl":"https://doi.org/10.4103/rcm.rcm_70_21","url":null,"abstract":"We present a case of funnel-shaped aneurysmal dilatation of left main coronary artery (LMCA) with aggressive stenosis of osteoproximal left circumflex coronary artery presenting with lateral wall coronary ischemia in a 6-year-old school-going child who recovered from Kawasaki disease (KD) 1 month back. Although aneurysmal dilatation of LMCA during first 2 months of recovery from KD is well known, with median duration for the development of stenotic lesion in coronaries after KD is approximately 6 months and all the cases of coronary stenosis described so far have been described in the presence of large coronary artery aneurysm, our case is rare to illustrate aggressive stenosis of osteoproximal left circumflex coronary artery just after 1 month of recovery in spite of the presence of small coronary artery aneurysm.","PeriodicalId":21031,"journal":{"name":"Research in Cardiovascular Medicine","volume":"11 1","pages":"39 - 42"},"PeriodicalIF":0.3,"publicationDate":"2022-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49455325","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
First 10 transcatheter pulmonary valve-in-valve procedures in rajaie cardiovascular medical and research center rajaie心血管医疗研究中心首个10个经导管肺动脉瓣中瓣手术
IF 0.3 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2022-01-01 DOI: 10.4103/rcm.rcm_67_21
S. Abdi, A. Firouzi, M. Alemzadeh-Ansari, Zahra Hosseini, A. Alizadehasl, Z. Khajali, S. Saedi, Nima Salehi, B. Koohestani, E. Khalilipur
Background: Transcatheter pulmonary valves (TPVs) are feasible and much less invasive options for surgical right ventricular outflow tract (RVOT) repair or valve replacement in patients with degeneration of the pulmonary valve bioprosthesis or RVOT conduit failure. In 2005, the first Sapien valve was implanted in the pulmonic position, and proceeding In March 2016, the Food and Drug Administration approved the SAPIEN valve (Edwards Lifesciences) for use in malfunctioning RVOT conduits. Material and method: We describe the first ten cases of TPV-in-valve procedure conducted in our center, along with the patients' prior surgical history, procedural details, and their clinical and echocardiographic data. Result and conclusion: Our data provided safety and efficacy of transcatheter valve-in-valve procedure in degenerated pulmonary bioprotheses and our follow-up proved durability of this procedure.
背景:对于肺动脉瓣生物瓣膜退化或右心室流出道导管故障的患者,经导管肺动脉瓣(TPV)是可行的、侵入性小得多的手术右心室流出路(RVOT)修复或瓣膜置换的选择。2005年,第一个Sapien瓣膜被植入肺动脉位置,2016年3月,美国食品药品监督管理局批准Sapien瓣膜(Edwards Lifesciences)用于出现故障的RVOT导管。材料和方法:我们描述了在我们中心进行的瓣膜手术中的前10例TPV,以及患者以前的手术史、手术细节以及他们的临床和超声心动图数据。结果和结论:我们的数据提供了经导管瓣膜置换术治疗退化性肺生物瓣膜的安全性和有效性,我们的随访证明了该手术的耐用性。
{"title":"First 10 transcatheter pulmonary valve-in-valve procedures in rajaie cardiovascular medical and research center","authors":"S. Abdi, A. Firouzi, M. Alemzadeh-Ansari, Zahra Hosseini, A. Alizadehasl, Z. Khajali, S. Saedi, Nima Salehi, B. Koohestani, E. Khalilipur","doi":"10.4103/rcm.rcm_67_21","DOIUrl":"https://doi.org/10.4103/rcm.rcm_67_21","url":null,"abstract":"Background: Transcatheter pulmonary valves (TPVs) are feasible and much less invasive options for surgical right ventricular outflow tract (RVOT) repair or valve replacement in patients with degeneration of the pulmonary valve bioprosthesis or RVOT conduit failure. In 2005, the first Sapien valve was implanted in the pulmonic position, and proceeding In March 2016, the Food and Drug Administration approved the SAPIEN valve (Edwards Lifesciences) for use in malfunctioning RVOT conduits. Material and method: We describe the first ten cases of TPV-in-valve procedure conducted in our center, along with the patients' prior surgical history, procedural details, and their clinical and echocardiographic data. Result and conclusion: Our data provided safety and efficacy of transcatheter valve-in-valve procedure in degenerated pulmonary bioprotheses and our follow-up proved durability of this procedure.","PeriodicalId":21031,"journal":{"name":"Research in Cardiovascular Medicine","volume":"11 1","pages":"13 - 19"},"PeriodicalIF":0.3,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48677831","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Inpatient cardiology consultation for COVID-19: What are cardiologists' diagnostic approaches? COVID-19住院心脏病会诊:心脏病专家的诊断方法是什么?
IF 0.3 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2022-01-01 DOI: 10.4103/rcm.rcm_45_21
Mitra Chitsazan, Mandana Chitsazan, A. Amin, S. Haehling, F. Naghashzadeh, Meysam Khoshavi, Mohammadreza Hoseinalizadeh, Sara Amini, N. Ziaie, S. Ghaffari, Raana Asghari, Afsaneh Amiri, Tania Garfias-Macedo, M. Maleki
Aim: Despite concerns about cardiovascular implications in coronavirus disease-2019 (COVID-19) patients, not all COVID-19 patients are visited by cardiologists and recommended to perform comprehensive cardiovascular assessments including measurement of biomarkers and echocardiography. We aimed to investigate the reasons for seeking cardiology care and to assess our cardiologists' diagnostic approaches to COVID-19 patients with potential cardiovascular involvement. Methods and Results: In this prospective, observational study, data of all consecutive COVID-19 patients admitted to six designated hospitals for COVID-19 in Iran in whom bedside cardiology consultation was requested were collected. A total of 148 patients including 105 (71%) males were included. The mean age was 57 ± 17 years. The most common reasons for cardiology consultation were dyspnea (56.7%), chest pain (12.8%), and suspected arrhythmias (10.8%). The most common comorbidities were hypertension (40.5%), diabetes mellitus (19.6%), and coronary heart disease (18.9%). A 12-lead electrocardiography (ECG) was obtained in all patients. Point-of-care ultrasonography or limited transthoracic echocardiography (TTE) was performed in 106 (71.6%) patients, and complete TTE was performed in 35 (23.4%) patients. Cardiac troponin was measured in 63 (42.6%) patients, and N-terminal pro B-type natriuretic peptide level was measured in 34 (23%) patients. Overall, 51 (34.5%) patients underwent invasive mechanical ventilation, inotropes were used in 29 (19.6%) patients, and 40 (27%) patients died. Conclusions: While preventing unnecessary investigations, the cardiologists should not overlook the lifesaving role of ubiquitous diagnostic modalities (such as ECG and TTE) in early detection and management of cardiac involvement in COVID-19.
目的:尽管人们担心2019冠状病毒病(新冠肺炎)患者的心血管影响,但并非所有新冠肺炎患者都接受了心脏病专家的访问,并建议他们进行全面的心血管评估,包括测量生物标志物和超声心动图。我们旨在调查寻求心脏病治疗的原因,并评估我们的心脏病专家对新冠肺炎潜在心血管疾病患者的诊断方法。方法和结果:在这项前瞻性观察性研究中,收集了在伊朗六家新冠肺炎定点医院入院的所有连续新冠肺炎患者的数据,这些患者要求进行床旁心脏病学咨询。共纳入148名患者,其中包括105名(71%)男性。平均年龄57±17岁。心脏病学咨询最常见的原因是呼吸困难(56.7%)、胸痛(12.8%)和疑似心律失常(10.8%)。最常见的合并症是高血压(40.5%)、糖尿病(19.6%)和冠心病(18.9%)。所有患者都进行了12导联心电图检查。106名(71.6%)患者接受了护理点超声心动图或有限经胸超声心动图(TTE)检查,35名(23.4%)患者接受完全经胸超声检查。在63名(42.6%)患者中测量了心肌肌钙蛋白,在34名(23%)患者中检测了N-末端B型利钠肽前体水平。总的来说,51名(34.5%)患者接受了有创机械通气,29名(19.6%)患者使用了止痛药,40名(27%)患者死亡。结论:在防止不必要的调查的同时,心脏病专家不应忽视普遍存在的诊断模式(如心电图和经胸超声心动图)在新冠肺炎心脏受累的早期检测和管理中的救生作用。
{"title":"Inpatient cardiology consultation for COVID-19: What are cardiologists' diagnostic approaches?","authors":"Mitra Chitsazan, Mandana Chitsazan, A. Amin, S. Haehling, F. Naghashzadeh, Meysam Khoshavi, Mohammadreza Hoseinalizadeh, Sara Amini, N. Ziaie, S. Ghaffari, Raana Asghari, Afsaneh Amiri, Tania Garfias-Macedo, M. Maleki","doi":"10.4103/rcm.rcm_45_21","DOIUrl":"https://doi.org/10.4103/rcm.rcm_45_21","url":null,"abstract":"Aim: Despite concerns about cardiovascular implications in coronavirus disease-2019 (COVID-19) patients, not all COVID-19 patients are visited by cardiologists and recommended to perform comprehensive cardiovascular assessments including measurement of biomarkers and echocardiography. We aimed to investigate the reasons for seeking cardiology care and to assess our cardiologists' diagnostic approaches to COVID-19 patients with potential cardiovascular involvement. Methods and Results: In this prospective, observational study, data of all consecutive COVID-19 patients admitted to six designated hospitals for COVID-19 in Iran in whom bedside cardiology consultation was requested were collected. A total of 148 patients including 105 (71%) males were included. The mean age was 57 ± 17 years. The most common reasons for cardiology consultation were dyspnea (56.7%), chest pain (12.8%), and suspected arrhythmias (10.8%). The most common comorbidities were hypertension (40.5%), diabetes mellitus (19.6%), and coronary heart disease (18.9%). A 12-lead electrocardiography (ECG) was obtained in all patients. Point-of-care ultrasonography or limited transthoracic echocardiography (TTE) was performed in 106 (71.6%) patients, and complete TTE was performed in 35 (23.4%) patients. Cardiac troponin was measured in 63 (42.6%) patients, and N-terminal pro B-type natriuretic peptide level was measured in 34 (23%) patients. Overall, 51 (34.5%) patients underwent invasive mechanical ventilation, inotropes were used in 29 (19.6%) patients, and 40 (27%) patients died. Conclusions: While preventing unnecessary investigations, the cardiologists should not overlook the lifesaving role of ubiquitous diagnostic modalities (such as ECG and TTE) in early detection and management of cardiac involvement in COVID-19.","PeriodicalId":21031,"journal":{"name":"Research in Cardiovascular Medicine","volume":"11 1","pages":"6 - 12"},"PeriodicalIF":0.3,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47449134","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical decision-making and personality traits; Achilles' heel of artificial intelligence 临床决策与人格特征;人工智能的致命弱点
IF 0.3 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2022-01-01 DOI: 10.4103/rcm.rcm_5_22
E. Khalilipur, M. Chinikar, Mehdi Mehrani, A. Elahifar
{"title":"Clinical decision-making and personality traits; Achilles' heel of artificial intelligence","authors":"E. Khalilipur, M. Chinikar, Mehdi Mehrani, A. Elahifar","doi":"10.4103/rcm.rcm_5_22","DOIUrl":"https://doi.org/10.4103/rcm.rcm_5_22","url":null,"abstract":"","PeriodicalId":21031,"journal":{"name":"Research in Cardiovascular Medicine","volume":"11 1","pages":"36 - 37"},"PeriodicalIF":0.3,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42916535","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Research in Cardiovascular Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1